Adopted opinions and previous consultations on applications for authorisation

Adopted opinions and previous consultations on applications for authorisation

Adopted opinions and previous consultations on applications for authorisation

This page provides further information on the applications for authorisation or review reports, which have undergone consultation. The applications for authorisation are in the opinion development phase until the final opinions of the Committees for Risk Assessment and Socio-economic Analysis have been adopted and sent to the European Commission. Its decision-making process can be followed through the comitology register, where further information is published about the REACH Committee's past and upcoming meetings.

On 1 February 2020, the United Kingdom (UK) withdrew from the EU. The transition period provided by the withdrawal agreement ended on 31 December 2020. As of 1 January 2021, an application for an authorisation submitted by a person established in the UK (except Northern Ireland) is no longer valid in the EU, unless that application has been transferred to a legal entity established in the EU or Northern Ireland before the end of the transition period. Therefore, authorisation applications and decisions in so far as these concern persons established in the UK (except Northern Ireland) are no longer considered valid. 

 

There are currently no ongoing consultations.
 
0157-01 Initial 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated - - Merck Biodevelopment SAS
Fujifilm Diosynth Biotechnologies (UK) Ltd - [Application void as of 01/01/2021]
Use of 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated as a detergent in the purification process of G-CSF (Granulocyte Colony Stimulating Factor) inclusion bodies Commission decided Details
0305-01 Initial Chromium trioxide 215-607-8 1333-82-0 Meoni e Bartoletti S.p.A. Use of Chromium Trioxide for the hard-chrome plating of hydraulic and pneumatic cylinders for various applications, and inner tubes of motorbike front suspension for the automotive industry. Opinion development Details
0299-01 Initial 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated - 9036-19-5 MeiraGTx Ireland Designated Activity Company Use of 4-tert-OPnEO as a manufacturing aid in the production of gene therapies Opinions adopted Details
0234-02 Initial Chromium trioxide 215-607-8 1333-82-0 Maschinenfabrik Kaspar Walter GmbH & Co KG Chromium trioxide-based functional chrome plating of cylinders used in the rotogravure printing and embossing industry. Opinions adopted Details
0234-01 Initial Chromium trioxide 215-607-8 1333-82-0 Maschinenfabrik Kaspar Walter GmbH & Co KG Formulation of chromium trioxide-based electrolyte for electroplating process. Opinions adopted Details
0270-01 Initial Chromium trioxide 215-607-8 1333-82-0 MAIER S. COOP. MAIER CZ s.r.o.; MAIER CROMOPLASTICA S.p.A Functional chrome plating with decorative character for automotive applications Opinions adopted Details
0270-02 Initial Chromium trioxide 215-607-8 1333-82-0 MAIER S. COOP. MAIER CZ s.r.o.; MAIER CROMOPLASTICA S.p.A Etching of plastics with chromium trioxide as pre-treatment step for electroplating of plastics for automotive applications Opinions adopted Details
0127-01 Initial Chromium trioxide 215-607-8 1333-82-0 MAHLE Ventiltrieb GmbH
MAHLE Polska Sp. z o.o.
Use of chromium trioxide in functional chrome plating of valves used in engines of light gasoline and diesel vehicles and in heavy duty diesel combustion engines Commission decided Details
0296-01 Initial Chromium trioxide 215-607-8 1333-82-0 MAHLE - Componentes de Motores, S.A. Chromium-trioxide-based functional chrome plating of piston rings for automotive applications Opinions adopted Details
0087-01 Initial Bis(2-methoxyethyl) ether (Diglyme) 203-924-4 111-96-6 MAFLON S.P.A. Use of bis(2-methoxyethyl) ether (diglyme) as a carrier solvent in the formulation and subsequent application of sodium naphthalide etchant for fluoropolymer surface modification whilst preserving article structural integrity. Commission decided Details